Plum SEC
  • Korean Market
  • Privacy Policy

Korean Market

  • Reset (View All)

  • ★★★★★
  • ★★★★
  • ★★★
  • ★★
  • ★

  • ★

  • ★
  • ★★
  • ★★★
  • ★★★★
  • ★★★★★
All Disclosures
OWNR
HLB
★★

Samsung Asset Management Reduces HLB Stake from 5.09% to 4.09%... Sold Over 1.33M Shares for Simple Investment

  05/29/2026, 03:57 PM
EXCH
HLB
★

HLB Holds NDR for Institutional Investors... IR Activity to Enhance Corporate Value

  05/29/2026, 01:59 PM
OTHR
HLB
★

Grant of Stock Options with Exercise Price 57,087 Won (Current Price 51,900 Won)

  05/18/2026, 04:45 PM
PERI
HLB
★

HLB Q1 2026 Results and Drug Development Progress: Rivoceranib FDA Resubmission, Lirafugratinib NDA Priority Review

  05/15/2026, 03:46 PM
한국어 | English | 中文 | 日本語
Plum SEC © 2026.05.25
The information provided on this site is for reference only and we do not guarantee its accuracy or completeness. Users are solely responsible for any investment decisions made based on this information.